The Urology and Andrology specialist participated as a speaker at the scientific congress held in Mallorca, addressing minimally invasive techniques for treating benign prostatic hyperplasia, a field that continues to evolve thanks to technologies such as Aquabeam.
Dr. Víctor Parejo Cortés, Medical Director of TAUS Clinics Menorca and a specialist in Urology and Andrology, participated as a speaker at the ABU 2026 Congress, held on 2 and 3 October at the Blau Punta Reina Hotel in Cala Mendia (Portocristo), Mallorca.
On Saturday, 3 October, Dr. Parejo delivered one of the scientific programme’s keynote lectures, entitled “Minimally Invasive Techniques for the Surgical Treatment of Benign Prostatic Hyperplasia”. The session was moderated by R. Guldris García from Hospital Universitari Son Espases.
His participation in this scientific meeting highlights the importance of continuous medical education and keeping up to date with new surgical approaches to one of the most common urological conditions affecting men.
New Techniques for Treating Benign Prostatic Hyperplasia
Benign prostatic hyperplasia (BPH) is a condition characterised by the non-cancerous enlargement of the prostate. It can cause difficulty urinating, increased urinary frequency and other symptoms that significantly affect quality of life.
In recent years, the development of minimally invasive procedures has expanded treatment options, allowing specialists to tailor surgical approaches to each patient’s individual characteristics and needs.
Dr. Víctor Parejo has extensive experience in different surgical techniques, including laser prostate vaporisation, Holmium Laser Enucleation of the Prostate (HoLEP) and Rezūm water vapour therapy.
His expertise in HoLEP is particularly noteworthy, having performed the procedure since 2014 and accumulated experience in more than 400 cases, according to information published by Andrología Mallorca.
Aquabeam: Robotic Technology Applied to Prostate Surgery
Among the technological advances in the treatment of benign prostatic hyperplasia is Aquabeam, the robotic system used to perform Aquablation therapy.
This technique removes prostate tissue obstructing urinary flow using a high-pressure waterjet, guided by imaging and following a treatment plan defined by the urologist.
Tissue resection is performed without thermal energy, which is one of its main differences compared with other surgical techniques.
Aquablation represents a surgical alternative for selected patients with benign prostatic hyperplasia. Clinical studies have shown improvements in urinary symptoms, while the technique is designed to help preserve sexual function, particularly ejaculatory function. However, suitability must be assessed individually, and potential complications should be discussed with a specialist.
Commitment to Urological Innovation in Menorca
Dr. Víctor Parejo’s participation in the ABU 2026 Congress reflects TAUS Clinics Menorca’s commitment to continuing medical education and keeping abreast of advanced techniques in Urology.
The experience of its medical professionals and their knowledge of evolving technologies such as Aquabeam contribute to specialised care based on scientific evidence and focused on individual patient needs.
At TAUS Clinics Menorca, the emphasis remains on personalised medicine, where accurate diagnosis and selecting the most appropriate treatment are essential to improving patients’ health and quality of life.
